title: Thirdhand smoke: a new dimension to the effects of cigarette smoke on the developing lung.
abstract: The underlying mechanisms and effector molecules involved in mediating in utero smoke exposure-induced effects on the developing lung are only beginning to be understood. However, the effects of a newly discovered category of smoke, i.e., thirdhand smoke (THS), on the developing lung are completely unknown. We hypothesized that, in addition to nicotine, other components of THS would also affect lung development adversely. Fetal rat lung explants were exposed to nicotine, 1-(N-methyl-N-nitrosamino)-1-(3-pyridinyl)-4-butanal (NNA), or 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), the two main tobacco-specific N-nitrosamine constituents of THS, for 24 h. We then determined key markers for alveolar paracrine signaling [epithelial differentiation markers surfactant phospholipid and protein synthesis; mesenchymal differentiation markers peroxisome proliferator-activated receptor γ (PPAR-γ), fibronectin and calponin], the BCL-2-to-Bax ratio (BCL-2/Bax), a marker of apoptosis and the involvement of nicotinic acetylcholine receptors (nAChR)-α3 and -α7 in mediating NNA's and NNK's effects on the developing lung. Similar to the effects of nicotine, exposure of the developing lung to either NNK or NNA resulted in disrupted homeostatic signaling, indicated by the downregulation of PPAR-γ, upregulation of fibronectin and calponin protein levels, decreased BCL-2/Bax, and the accompanying compensatory stimulation of surfactant phospholipid and protein synthesis. Furthermore, nAChR-α3 and -α7 had differential complex roles in mediating these effects. NNK and NNA exposure resulted in breakdown of alveolar epithelial-mesenchymal cross-talk, reflecting lipofibroblast-to-myofibroblast transdifferentiation, suggesting THS constituents as possible novel contributors to in utero smoke exposure-induced pulmonary damage. These data are particularly relevant for designing specific therapeutic strategies, and for formulating public health policies to minimize THS exposure.
authors.affiliation: Departments of Pediatrics, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California 90502, USA. vrehan@labiomed.org
authors.forename: Virender K
authors.initials: VK
authors.lastname: Rehan
authors.forename: Reiko
authors.initials: R
authors.lastname: Sakurai
authors.forename: John S
authors.initials: JS
authors.lastname: Torday
mesh_terms: D000447:Aldehydes / Q000633:toxicity; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002038:Bungarotoxins / Q000494:pharmacology; D002135:Calcium-Binding Proteins / Q000378:metabolism; D008168:Lung / Q000187:drug effects* / Q000196:embryology* / Q000473:pathology; D008464:Mecamylamine / Q000494:pharmacology; D008840:Microfilament Proteins / Q000378:metabolism; D009538:Nicotine / Q000633:toxicity; D009602:Nitrosamines / Q000633:toxicity; D047495:PPAR gamma / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011978:Receptors, Nicotinic / Q000378:metabolism; D012907:Smoking / Q000009:adverse effects*; D014028:Tobacco Smoke Pollution / Q000009:adverse effects*; D000096985:Calponins
chemical_list: D000447:Aldehydes; D002038:Bungarotoxins; D002135:Calcium-Binding Proteins; D008464:Mecamylamine; D008840:Microfilament Proteins; D009538:Nicotine; D009602:Nitrosamines; D047495:PPAR gamma; D019253:Proto-Oncogene Proteins c-bcl-2; D011978:Receptors, Nicotinic; D014028:Tobacco Smoke Pollution; D000096985:Calponins; C016583:4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; C018475:butyraldehyde